Market Introduction
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system. Multiple sclerosis is a widespread disabling neurological condition, mostly diagnosed in people in the age group 20–50 years. It is a potentially debilitating disease, causing disruption in communication and coordination functions of the body.
Market Overview and Dynamics
The Middle East and Africa multiple sclerosis therapeutics market is expected to reach US$ 2,027.86 million by 2027 from US$ 1,319.08 million in 2019; it is estimated to grow at a CAGR of 5.7% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as increasing awareness about multiple sclerosis amongst population, and development and launch of innovative products. However, the high cost of the multiple sclerosis treatment hinders the market growth.
Multiple sclerosis (MS) is a chronic disease that affects the brain, spinal cord, and optic nerves. Studies show that there is an increase in the prevalence of multiple sclerosis across the Middle East and African countries. In recent years, various measures and efforts have been taken to create awareness and educate people regarding neurological diseases, which are facilitating patients to access suitable medications and treatments for such conditions. The Multiple Sclerosis Foundation and affiliated groups have initiated National MS Education and Awareness Month, which is observed in March since 2003 to increase awareness about the disease. The goal of this program is to promote an understanding of Multiple Sclerosis and help the patients in making educated decisions of its treatment. Also, the National MS Society created and launched the “MS Kills Connection > < Connection Kills MS” campaign to connect people suffering from MS, people who treat MS patients, and people who run activities to create a world free of MS. Similarly, several players operating in the multiple sclerosis therapeutics market are developing and launching new products. The strategy of geographic and manufacturing capacity expansion, along with the product launches, helps companies cater to a broad customer base. Such developments and launches of new products are emerging as a key trend in the Middle East and Africa multiple sclerosis therapeutics market.
Middle East and Africa is recording the growing number of COVID-19 cases. The COVID-19 pandemic restricted the research and development activities in countries across the region in 2020. Apart from this, a huge population already face a growing burden of non-communicable diseases like hypertension and diabetes, which is making them more vulnerable to the novel coronavirus. The countries in these regions are highly dependent on pharmaceutical products imported from developed countries. Therefore, massive disruptions in supply chains are hindering the growth of the Middle East and Africa multiple sclerosis therapeutics market.
Key Market Segments
The Middle East and Africa multiple sclerosis therapeutics market, by drug class, is bifurcated into immunosuppressant and immunomodulators. The immunomodulators segment held a larger share of the market in 2019, whereas the immunosuppressants segment is anticipated to register a higher CAGR in the market during the forecast period.
The Middle East and Africa multiple sclerosis therapeutics market, by route of administration, is bifurcated into injectable and oral. The injectable segment held a larger share of the market in 2019, and the same segment is anticipated to register a higher CAGR in the market during the forecast period.
Based on distribution channel, the Middle East and Africa multiple sclerosis therapeutics market is segmented into hospital pharmacies, retail pharmacies, and e-commerce. The hospital pharmacies segment held the largest share of the market in 2019. However, the e-commerce segment is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
Some of the primary and secondary sources associated with this report on the Middle East and Africa multiple sclerosis therapeutics market are the Multiple Sclerosis Scientific Research Foundation (MSSRF), World Health Organization (WHO), and Ministry of Health and Prevention (MoHAP).
Reasons to buy the report
MIDDLE EAST AND AFRICA MULTIPLE SCLEROSIS THERAPEUTICS MARKET SEGMENTATION
By Drug Class
By Route of Administration
By Distribution Channel
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,319.08 Million |
| Market Size by 2027 | US$ 2,027.86 Million |
| CAGR (2020 - 2027) | 5.7% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Drug Class
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Multiple Sclerosis Therapeutics Market is valued at US$ 1,319.08 Million in 2019, it is projected to reach US$ 2,027.86 Million by 2027.
As per our report Middle East and Africa Multiple Sclerosis Therapeutics Market, the market size is valued at US$ 1,319.08 Million in 2019, projecting it to reach US$ 2,027.86 Million by 2027. This translates to a CAGR of approximately 5.7% during the forecast period.
The Middle East and Africa Multiple Sclerosis Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Multiple Sclerosis Therapeutics Market report:
The Middle East and Africa Multiple Sclerosis Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Multiple Sclerosis Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Multiple Sclerosis Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Multiple Sclerosis Therapeutics Market
